ATE486848T1 - Verfahren zur herstellung von ezetimibe und in diesem verfahren eingesetzte zwischenprodukte - Google Patents
Verfahren zur herstellung von ezetimibe und in diesem verfahren eingesetzte zwischenprodukteInfo
- Publication number
- ATE486848T1 ATE486848T1 AT06831516T AT06831516T ATE486848T1 AT E486848 T1 ATE486848 T1 AT E486848T1 AT 06831516 T AT06831516 T AT 06831516T AT 06831516 T AT06831516 T AT 06831516T AT E486848 T1 ATE486848 T1 AT E486848T1
- Authority
- AT
- Austria
- Prior art keywords
- intermediate products
- products used
- silyl
- ezetimibe
- viii
- Prior art date
Links
- 238000000034 method Methods 0.000 title abstract 3
- OLNTVTPDXPETLC-XPWALMASSA-N ezetimibe Chemical compound N1([C@@H]([C@H](C1=O)CC[C@H](O)C=1C=CC(F)=CC=1)C=1C=CC(O)=CC=1)C1=CC=C(F)C=C1 OLNTVTPDXPETLC-XPWALMASSA-N 0.000 title abstract 2
- 229960000815 ezetimibe Drugs 0.000 title 1
- 239000013067 intermediate product Substances 0.000 title 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- -1 e.g. Chemical group 0.000 abstract 1
- 125000001181 organosilyl group Chemical group [SiH3]* 0.000 abstract 1
- 239000000126 substance Substances 0.000 abstract 1
- 125000001981 tert-butyldimethylsilyl group Chemical group [H]C([H])([H])[Si]([H])(C([H])([H])[H])[*]C(C([H])([H])[H])(C([H])([H])[H])C([H])([H])[H] 0.000 abstract 1
- 125000000037 tert-butyldiphenylsilyl group Chemical group [H]C1=C([H])C([H])=C([H])C([H])=C1[Si]([H])([*]C(C([H])([H])[H])(C([H])([H])[H])C([H])([H])[H])C1=C([H])C([H])=C([H])C([H])=C1[H] 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D205/00—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom
- C07D205/02—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings
- C07D205/06—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
- C07D205/08—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with one oxygen atom directly attached in position 2, e.g. beta-lactams
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D317/00—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
- C07D317/08—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
- C07D317/10—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 not condensed with other rings
- C07D317/14—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 not condensed with other rings with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D317/30—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/06—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F7/00—Compounds containing elements of Groups 4 or 14 of the Periodic Table
- C07F7/02—Silicon compounds
- C07F7/08—Compounds having one or more C—Si linkages
- C07F7/18—Compounds having one or more C—Si linkages as well as one or more C—O—Si linkages
- C07F7/1804—Compounds having Si-O-C linkages
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F7/00—Compounds containing elements of Groups 4 or 14 of the Periodic Table
- C07F7/02—Silicon compounds
- C07F7/08—Compounds having one or more C—Si linkages
- C07F7/18—Compounds having one or more C—Si linkages as well as one or more C—O—Si linkages
- C07F7/1804—Compounds having Si-O-C linkages
- C07F7/1872—Preparation; Treatments not provided for in C07F7/20
- C07F7/1892—Preparation; Treatments not provided for in C07F7/20 by reactions not provided for in C07F7/1876 - C07F7/1888
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Plural Heterocyclic Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
- Multi-Process Working Machines And Systems (AREA)
- Management, Administration, Business Operations System, And Electronic Commerce (AREA)
- General Factory Administration (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Cephalosporin Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| HU0501164A HUP0501164A2 (en) | 2005-12-20 | 2005-12-20 | New industrial process for the production of ezetimibe |
| PCT/HU2006/000116 WO2007072088A1 (en) | 2005-12-20 | 2006-12-18 | Process for the production of ezetimibe and intermediates used in this proces |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE486848T1 true ATE486848T1 (de) | 2010-11-15 |
Family
ID=37492156
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT06831516T ATE486848T1 (de) | 2005-12-20 | 2006-12-18 | Verfahren zur herstellung von ezetimibe und in diesem verfahren eingesetzte zwischenprodukte |
Country Status (18)
| Country | Link |
|---|---|
| US (1) | US8178665B2 (de) |
| EP (1) | EP1963260B1 (de) |
| CN (1) | CN101346349B (de) |
| AT (1) | ATE486848T1 (de) |
| CA (1) | CA2630737A1 (de) |
| CY (1) | CY1111307T1 (de) |
| DE (1) | DE602006018063D1 (de) |
| DK (1) | DK1963260T3 (de) |
| EA (1) | EA014331B1 (de) |
| ES (1) | ES2354728T3 (de) |
| HK (1) | HK1128156A1 (de) |
| HR (1) | HRP20110013T1 (de) |
| HU (2) | HU0501164D0 (de) |
| PL (1) | PL1963260T3 (de) |
| PT (1) | PT1963260E (de) |
| RS (1) | RS51613B (de) |
| SI (1) | SI1963260T1 (de) |
| WO (1) | WO2007072088A1 (de) |
Families Citing this family (35)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1699759B1 (de) | 2003-12-23 | 2010-10-20 | AstraZeneca AB | Diphenylazetidinonderivate mit die cholesterinabsorption hemmender wirkung |
| CA2591564A1 (en) | 2004-12-20 | 2006-06-29 | Schering Corporation | Process for the synthesis of azetidinones |
| UY29607A1 (es) | 2005-06-20 | 2007-01-31 | Astrazeneca Ab | Compuestos quimicos |
| AR057072A1 (es) | 2005-06-22 | 2007-11-14 | Astrazeneca Ab | Compuestos quimicos derivados de 2-azetidinona, formulacion farmaceutica y un proceso de preparacion del compuesto |
| SA06270191B1 (ar) | 2005-06-22 | 2010-03-29 | استرازينيكا ايه بي | مشتقات من 2- أزيتيدينون جديدة باعتبارها مثبطات لامتصاص الكوليسترول لعلاج حالات فرط نسبة الدهون في الدم |
| WO2007119106A2 (en) * | 2005-12-22 | 2007-10-25 | Medichem, S.A. | Processes for preparing intermediate compounds useful for the preparation of ezetimibe |
| WO2007144780A2 (en) * | 2006-03-29 | 2007-12-21 | Medichem S.A. | Processes for preparing ezetimibe and intermediate compounds useful for the preparation thereof |
| EP2004639A2 (de) * | 2006-04-10 | 2008-12-24 | Teva Pharmaceutical Industries Ltd | Verfahren zur synthese von azetinidon |
| AR060623A1 (es) | 2006-04-27 | 2008-07-02 | Astrazeneca Ab | Compuestos derivados de 2-azetidinona y un metodo de preparacion |
| KR20080053948A (ko) * | 2006-08-29 | 2008-06-16 | 테바 파마슈티컬 인더스트리즈 리미티드 | (3ｒ,4ｓ)-4-(4-히드록시-보호된-페닐)-1-(4-플루오로페닐)-3-[3-(4-플루오로페닐)-3-옥소프로필]아제티딘-2-온의정제 방법 |
| CZ302395B6 (cs) * | 2007-03-02 | 2011-04-27 | Zentiva, A. S. | Zpusob výroby (3R,4S)-1-(4-fluorfenyl)-3-[(3S)-3-(4-fluorfenyl)-3-hydroxypropyl)]-4-(4-hydroxyfenyl)-2-azetidinonu |
| CZ2007843A3 (cs) * | 2007-11-30 | 2009-06-10 | Zentiva, A. S. | Zpusob výroby (3R,4S)-1-(4-fluorfenyl)-3-[(3S)-3-(4-fluorfenyl)-3-hydroxypropyl)]-4-(4-hydroxyfenyl)-2-azetidinonu a jeho meziprodukty |
| CZ2008317A3 (cs) * | 2008-05-21 | 2009-12-02 | Zentiva, A. S. | Zpusob výroby (3R,4S)-1-(4-fluorfenyl)-3-[(3S)-3-(4-fluorfenyl)-3-hydroxypropyl)]-4-(4-hydroxyfenyl)-2-azetidinonu |
| AR074752A1 (es) * | 2008-12-17 | 2011-02-09 | Hanmi Pharm Ind Co Ltd | Metodo para preparar ezetimiba e intermediarios usados en la misma |
| US9388440B2 (en) | 2009-04-01 | 2016-07-12 | Mylan Laboratories Limited | Enzymatic process for the preparation of (S)-5-(4-fluoro-phenyl)-5-hydroxy-1morpholin-4-yl-pentan-1-one, an intermediate of Ezetimibe and further conversion to Ezetimibe |
| CN101935309B (zh) * | 2009-06-29 | 2013-11-13 | 上海特化医药科技有限公司 | 依泽替米贝的制备方法及其中间体 |
| US8781844B2 (en) | 2009-09-25 | 2014-07-15 | Nokia Corporation | Audio coding |
| US9040262B2 (en) | 2010-05-04 | 2015-05-26 | Codexis, Inc. | Biocatalysts for ezetimibe synthesis |
| ES2372460B1 (es) | 2010-07-09 | 2012-11-16 | Moehs Ibérica S.L. | Nuevo método para la preparación de ezetimiba. |
| CN102477008B (zh) * | 2010-11-22 | 2014-05-21 | 沈阳药科大学 | 依泽替米贝的合成方法 |
| WO2012076030A1 (en) | 2010-12-10 | 2012-06-14 | Pharmathen S.A. | Process for the preparation of intermediate compounds useful in the preparation of ezetimibe |
| CN102731489B (zh) * | 2011-04-11 | 2016-10-26 | 天津药物研究院有限公司 | 一种依折麦布关键中间体的制备方法 |
| CN102952055A (zh) * | 2011-08-16 | 2013-03-06 | 凯瑞斯德生化(苏州)有限公司 | 一种依泽替米贝和其中间体的制备方法 |
| CN103204795B (zh) * | 2012-01-11 | 2016-12-14 | 重庆华邦胜凯制药有限公司 | 一种手性氮杂环丁酮类化合物的制备方法 |
| CN103896700B (zh) * | 2012-12-25 | 2015-12-23 | 浙江九洲药物科技有限公司 | 依泽替米贝手性中间体的制备方法 |
| CN103450065B (zh) * | 2013-07-15 | 2015-10-14 | 和鼎（南京）医药技术有限公司 | 制备依泽替米贝的方法 |
| CN103739537B (zh) * | 2013-12-24 | 2015-05-20 | 连云港恒运医药科技有限公司 | 依折麦布的新合成方法 |
| CN104892537B (zh) * | 2015-05-15 | 2018-07-17 | 江西施美药业股份有限公司 | 依折麦布中间体以及依折麦布的合成方法 |
| CN105566243B (zh) * | 2016-01-15 | 2017-10-31 | 齐鲁天和惠世制药有限公司 | 从依折麦布生产废液中回收(s)‑(+)‑4‑苯基‑2‑噁唑烷酮的方法 |
| CN107098841A (zh) * | 2016-02-19 | 2017-08-29 | 常州方楠医药技术有限公司 | 一种依折麦布的制备方法及该方法中所用的中间体 |
| CN107488138B (zh) * | 2016-06-10 | 2021-05-04 | 山东新时代药业有限公司 | 一种依折麦布合成方法 |
| CN107488164B (zh) * | 2016-06-10 | 2020-08-14 | 山东新时代药业有限公司 | 一种依折麦布中间体化合物 |
| CN107488165B (zh) * | 2016-06-10 | 2021-05-04 | 山东新时代药业有限公司 | 一种依折麦布中间体化合物 |
| CN107488173B (zh) * | 2016-06-10 | 2021-05-04 | 山东新时代药业有限公司 | 一种依折麦布中间体及其合成方法 |
| CN107488190B (zh) * | 2016-06-10 | 2021-07-02 | 山东新时代药业有限公司 | 一种依折麦布中间体及其制备方法 |
Family Cites Families (26)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5631365A (en) * | 1993-09-21 | 1997-05-20 | Schering Corporation | Hydroxy-substituted azetidinone compounds useful as hypocholesterolemic agents |
| AU7361796A (en) | 1995-09-27 | 1997-04-17 | Schering Corporation | Stereoselective microbial reduction process |
| US5618707A (en) * | 1996-01-04 | 1997-04-08 | Schering Corporation | Stereoselective microbial reduction of 5-fluorophenyl-5-oxo-pentanoic acid and a phenyloxazolidinone condensation product thereof |
| AU7472896A (en) * | 1995-11-02 | 1997-05-22 | Schering Corporation | Process for preparing 1-(4-fluorophenyl)-3(r)-(3(s)-hydroxy-3-({phenyl or 4-fluorophenyl})-propyl)-4(s)-(4-hydroxyphenyl)-2-azetidinon |
| US5739321A (en) * | 1996-05-31 | 1998-04-14 | Schering Corporation | 3-hydroxy γ-lactone based enantionselective synthesis of azetidinones |
| US5886171A (en) * | 1996-05-31 | 1999-03-23 | Schering Corporation | 3-hydroxy gamma-lactone based enantioselective synthesis of azetidinones |
| US6133001A (en) * | 1998-02-23 | 2000-10-17 | Schering Corporation | Stereoselective microbial reduction for the preparation of 1-(4-fluorophenyl)-3(R)-[3(S)-Hydroxy-3-(4-fluorophenyl)propyl)]-4(S)-(4 -hydroxyphenyl)-2-azetidinone |
| US5919672A (en) * | 1998-10-02 | 1999-07-06 | Schering Corporation | Resolution of trans-2-(alkoxycarbonylethyl)-lactams useful in the synthesis of 1-(4-fluoro-phenyl)-3(R)- (S)-hydroxy-3-(4-fluorophenyl)-propyl!-4(S)-(4-hydroxyphenyl)-2-azetidinone |
| US6207822B1 (en) | 1998-12-07 | 2001-03-27 | Schering Corporation | Process for the synthesis of azetidinones |
| CA2353981C (en) * | 1998-12-07 | 2005-04-26 | Schering Corporation | Process for the synthesis of azetidinones |
| EE05453B1 (et) * | 2001-03-28 | 2011-08-15 | Schering Corporation | Protsess asetidinoonvahehendite valmistamiseks |
| WO2005066120A2 (en) | 2003-12-30 | 2005-07-21 | Ranbaxy Laboratories Limited | Process for asymmetric synthesis of hydroxy-alkyl substituted azetidinone derivatives |
| CA2613239A1 (en) * | 2005-06-22 | 2006-12-28 | Manne Satyanarayana Reddy | Improved process for the preparation of ezetimibe |
| CA2616058A1 (en) * | 2005-09-08 | 2007-03-15 | Vinod Kumar Kansal | Processes for the preparation of (3r,4s)-4-((4-benzyloxy)phenyl)-1-(4-fluorophenyl)-3-((s)-3-(4-fluorophenyl)-3-hydroxypropyl)-2-azetidinone, an intermediate for the synthesis of ezetimibe |
| WO2007119106A2 (en) * | 2005-12-22 | 2007-10-25 | Medichem, S.A. | Processes for preparing intermediate compounds useful for the preparation of ezetimibe |
| WO2007144780A2 (en) * | 2006-03-29 | 2007-12-21 | Medichem S.A. | Processes for preparing ezetimibe and intermediate compounds useful for the preparation thereof |
| EP2004639A2 (de) * | 2006-04-10 | 2008-12-24 | Teva Pharmaceutical Industries Ltd | Verfahren zur synthese von azetinidon |
| KR20080053948A (ko) * | 2006-08-29 | 2008-06-16 | 테바 파마슈티컬 인더스트리즈 리미티드 | (3ｒ,4ｓ)-4-(4-히드록시-보호된-페닐)-1-(4-플루오로페닐)-3-[3-(4-플루오로페닐)-3-옥소프로필]아제티딘-2-온의정제 방법 |
| CN102285906B (zh) * | 2007-01-24 | 2014-11-19 | 克尔克公司 | 依泽替米贝的制备方法和其的衍生物 |
| CZ302395B6 (cs) * | 2007-03-02 | 2011-04-27 | Zentiva, A. S. | Zpusob výroby (3R,4S)-1-(4-fluorfenyl)-3-[(3S)-3-(4-fluorfenyl)-3-hydroxypropyl)]-4-(4-hydroxyfenyl)-2-azetidinonu |
| US20090047716A1 (en) * | 2007-06-07 | 2009-02-19 | Nurit Perlman | Reduction processes for the preparation of ezetimibe |
| US20080318920A1 (en) * | 2007-06-19 | 2008-12-25 | Protia, Llc | Deuterium-enriched ezetimibe |
| WO2009032264A1 (en) * | 2007-08-30 | 2009-03-12 | Teva Pharmaceutical Industries Ltd. | Processes for preparing intermediates of ezetimibe by microbial reduction |
| CZ2007843A3 (cs) * | 2007-11-30 | 2009-06-10 | Zentiva, A. S. | Zpusob výroby (3R,4S)-1-(4-fluorfenyl)-3-[(3S)-3-(4-fluorfenyl)-3-hydroxypropyl)]-4-(4-hydroxyfenyl)-2-azetidinonu a jeho meziprodukty |
| CZ305066B6 (cs) * | 2008-02-25 | 2015-04-22 | Zentiva, K.S. | Způsob výroby (3R,4S)-1-(4-fluorfenyl)-3-[(3S)-3-(4-fluorfenyl)-3-hydroxypropyl)]-4-(4-hydroxyfenyl)-2-azetidinonu |
| CZ2008317A3 (cs) * | 2008-05-21 | 2009-12-02 | Zentiva, A. S. | Zpusob výroby (3R,4S)-1-(4-fluorfenyl)-3-[(3S)-3-(4-fluorfenyl)-3-hydroxypropyl)]-4-(4-hydroxyfenyl)-2-azetidinonu |
-
2005
- 2005-12-20 HU HU0501164A patent/HU0501164D0/hu unknown
- 2005-12-20 HU HU0501164A patent/HUP0501164A2/hu unknown
-
2006
- 2006-12-18 SI SI200630888T patent/SI1963260T1/sl unknown
- 2006-12-18 PL PL06831516T patent/PL1963260T3/pl unknown
- 2006-12-18 AT AT06831516T patent/ATE486848T1/de active
- 2006-12-18 EA EA200801548A patent/EA014331B1/ru unknown
- 2006-12-18 WO PCT/HU2006/000116 patent/WO2007072088A1/en active Application Filing
- 2006-12-18 DE DE602006018063T patent/DE602006018063D1/de active Active
- 2006-12-18 DK DK06831516.7T patent/DK1963260T3/da active
- 2006-12-18 RS RS20100505A patent/RS51613B/en unknown
- 2006-12-18 US US12/097,185 patent/US8178665B2/en not_active Expired - Fee Related
- 2006-12-18 ES ES06831516T patent/ES2354728T3/es active Active
- 2006-12-18 EP EP06831516A patent/EP1963260B1/de active Active
- 2006-12-18 CA CA002630737A patent/CA2630737A1/en not_active Abandoned
- 2006-12-18 CN CN2006800485754A patent/CN101346349B/zh not_active Expired - Fee Related
- 2006-12-18 PT PT06831516T patent/PT1963260E/pt unknown
-
2009
- 2009-06-30 HK HK09105859.0A patent/HK1128156A1/xx not_active IP Right Cessation
-
2010
- 2010-12-27 CY CY20101101193T patent/CY1111307T1/el unknown
-
2011
- 2011-01-11 HR HR20110013T patent/HRP20110013T1/hr unknown
Also Published As
| Publication number | Publication date |
|---|---|
| EA014331B1 (ru) | 2010-10-29 |
| PL1963260T3 (pl) | 2011-04-29 |
| CY1111307T1 (el) | 2015-08-05 |
| WO2007072088A1 (en) | 2007-06-28 |
| US20090216009A1 (en) | 2009-08-27 |
| CN101346349A (zh) | 2009-01-14 |
| HUP0501164A2 (en) | 2007-07-30 |
| SI1963260T1 (sl) | 2011-02-28 |
| EA200801548A1 (ru) | 2008-10-30 |
| RS51613B (en) | 2011-08-31 |
| CA2630737A1 (en) | 2007-06-28 |
| HK1128156A1 (en) | 2009-10-16 |
| DK1963260T3 (da) | 2011-01-17 |
| HRP20110013T1 (hr) | 2011-02-28 |
| DE602006018063D1 (de) | 2010-12-16 |
| EP1963260A1 (de) | 2008-09-03 |
| HU0501164D0 (en) | 2006-02-28 |
| US8178665B2 (en) | 2012-05-15 |
| ES2354728T3 (es) | 2011-03-17 |
| EP1963260B1 (de) | 2010-11-03 |
| CN101346349B (zh) | 2011-04-20 |
| PT1963260E (pt) | 2010-12-27 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE486848T1 (de) | Verfahren zur herstellung von ezetimibe und in diesem verfahren eingesetzte zwischenprodukte | |
| EA200300970A1 (ru) | Энантиоселективный синтез промежуточных соединений для получения азетидинонов | |
| DE60316688D1 (de) | Dehydrophenylahistine und analoge davon sowie ein verfahren zur herstellung von dehydrophenylahistinen und analogen davon | |
| GB0313612D0 (en) | Organic compounds | |
| MY149146A (en) | Processes and intermediates useful in the preparation of pharmaceutical compounds such as fulvestrant | |
| DE60327571D1 (de) | Verfahren zur Herstellung von Polymerverbindungen durch Eliminierungsreaktion | |
| ATE377593T1 (de) | 9,10-alpha,alpha-oh-taxananaloga und verfahren zu deren herstellung | |
| ATE442355T1 (de) | Herstellung von 4,5-dialkyl-3-acylpyrrol-2- carbonsäurederivaten durch synthese nach fischer- fink und anschliebende acylierung | |
| Andreoli et al. | β-Lactams from ester enolates and silylimines: An enantiospecific synthesis of monocyclic β-lactams. | |
| Alcaide et al. | A new radical route to C4-unsubstituted β-lactams | |
| ATE450509T1 (de) | Kationische alkoxyaminen zur verwendung in der herstellung von nanopartikeln von natürlichen oder synthetischen clays | |
| ATE201410T1 (de) | Verfahren zur herstellung von 1-(4,5-dihydro)2- thiazolyl-3-azetidinthiolderivaten | |
| ATE415404T1 (de) | Lösungsmittelfreies verfahren zur herstellung von diketopyrrolopyrrol-derivaten | |
| DE60116201D1 (de) | Verfahren zur Herstellung von Cephalosporin-Verbindungen und Zwischenprodukte für die Synthese dieser Verbindungen | |
| MXPA05008525A (es) | Oxatiincarboxamidas. | |
| ATE223414T1 (de) | Prozess zur herstellung von zwischebprodukten für imidazodeazepinen | |
| UA99702C2 (ru) | Способ получения эзетимиба и промежуточных продуктов, используемых в этом способе | |
| ATE444323T1 (de) | Neuartige epoxidverbindungen und verfahren zu ihrer herstellung | |
| TW200720282A (en) | Novel organosilicon compound and process for producing the same | |
| DE60112241D1 (de) | Verfahren und zwischenverbindungen zur herstellung von imidazopyridinen | |
| Thomas et al. | Development of a synthesis of lankacidins: stereoselective synthesis of the δ-lactone fragment | |
| ATE162518T1 (de) | 4-substituierte azetidinone als vorläufer zu 2- substituierte-3-carbonsäure-carbapenem- antibiotika und ein verfahren zu ihrer herstellung | |
| DE50203881D1 (de) | Markierungsfähige verbindungen zur einfachen synthese von 3'-[18f]fluor-3'-deoxythymidin und verfahren zu deren herstellung | |
| ATE374758T1 (de) | Chirale heptinderivate zur herstellung von epothilonen und verfahren zu deren herstellung | |
| MEP56208A (en) | Caloporoside derivatives, methods for the production thereof and their use |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| UEP | Publication of translation of european patent specification |
Ref document number: 1963260 Country of ref document: EP |